Chronological changes and effects of AMP- activated kinase in the hippocampal CA1 region after transient forebrain ischemia in gerbils

Neurological Research

Volumn 35, Issue 4, 2013, Pages 395-405

  Nam, Han Ga Wi ^a   Kim, Woosuk ^b   Yoo, Dae Young ^b   Choi, Jung Hoon ^c   Won, Moo Ho ^c   Hwang, In Koo ^b   Jeong, Je Hoon ^a   Hwang, Hyung Sik ^a   Moon, Seung Myung ^a  

^a Hallym University   (South Korea)

^b Seoul National University   (South Korea)

^c Kangwon National University   (South Korea)

Author keywords

Adenosine monophosphate activated kinase; Gerbil; Lactate; Neuroprotection; Transient forebrain ischemia

Indexed keywords

ADENOSINE TRIPHOSPHATE; COMPOUND C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LACTIC ACID; PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN ISCHEMIA; CONTROLLED STUDY; GERBIL; GLIOSIS; HIPPOCAMPAL CA1 REGION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIMIT OF QUANTITATION; MALE; MICROGLIA; MOTOR ACTIVITY; NEUROPROTECTION; NONHUMAN; PROTEIN PHOSPHORYLATION; REPERFUSION; STRATUM PYRAMIDALE;

ADENYLATE KINASE; ANIMALS; CA1 REGION, HIPPOCAMPAL; ENZYME INHIBITORS; GERBILLINAE; IMMUNOHISTOCHEMISTRY; ISCHEMIC ATTACK, TRANSIENT; MALE; NEUROPROTECTIVE AGENTS; PROSENCEPHALON; PYRAZOLES; PYRIMIDINES; TIME;

EID: 84875451484     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132813Y.0000000158     Document Type: Article

References (43)

1. Misra P. AMP activated protein kinase: a next generation target for total metabolic control. Expert Opin Ther Targets. 2008;12:91-100.
2. Spasić MR, Callaerts P, Norga KK. AMP-activated protein kinase (AMPK) molecular crossroad for metabolic control and survival of neurons. Neuroscientist. 2009;15:309-16.
3. Blanco Martínez de Morentin P, González CR, Saha AK, Martins L, Diéguez C, Vidal-Puig A, et al. Hypothalamic AMP-activated protein kinase as a mediator of whole body energy balance. Rev Endocr Metab Disord. 2011;12:127-40.
4. Minokoshi Y, Shiuchi T, Lee S, Suzuki A, Okamoto S. Role of hypothalamic AMP-kinase in food intake regulation. Nutrition. 2008;24:786-90.
5. Ramamurthy S, Ronnett GV. Developing a head for energy sensing: AMP-activated protein kinase as a multifunctional metabolic sensor in the brain. J Physiol. 2006;574:85-93
6. Ronnett GV, Ramamurthy S, Kleman AM, Landree LE, Aja S. AMPK in the brain: its roles in energy balance and neuroprotection. J Neurochem. 2009;109(Suppl 1):17-23.
7. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 1982;239:57-69.
8. Lin CS, Polsky K, Nadler JV, Crain BJ. Selective neocortical and thalamic cell death in the gerbil after transient ischemia. Neuroscience. 1990;35:289-99.
9. Petito CK, Pulsinelli WA. Delayed neuronal recovery and neuronal death in rat hippocampus following severe cerebral ischemia: possible relationship to abnormalities in neuronal processes. J Cereb Blood Flow Metab. 1984;4:194-205.
10. Danielisová V, Gottlieb M, Némethová M, Burda J. Activities of endogenous antioxidant enzymes in the cerebrospinal fluid and the hippocampus after transient forebrain ischemia in rat. J Neurol Sci. 2007;253:61-5.
11. Shigenaga MK, Hagen TM, Ames BN. Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci U S A. 1994; 91:10771-8.
12. Loskota WA, Lomax P, Verity MA. A stereotaxic atlas of the Mongolian gerbil brain (Meriones unguiculatus). Ann Arbor, MI: Science Publishers Inc.; 1974. pp. 70-9.
13. Janać B, Selaković V, Radenović L. Temporal patterns of motor behavioural improvements by MK-801 in Mongolian gerbils submitted to different duration of global cerebral ischemia. Behav Brain Res. 2008;194:72-8.
14. Lee CH, Park OK, Yoo KY, Byun K, Lee B, Choi JH, et al. The role of peroxisome proliferator-activated receptor c, and effects of its agonist, rosiglitazone, on transient cerebral ischemic damage. J Neurol Sci. 2011;300:120-9.
15. Lee CH, Yan B, Yoo KY, Choi JH, Kwon SH, Her S, et al. Ischemia-induced changes in glucagon-like peptide-1 receptor and neuroprotective effect of its agonist, exendin-4, in experimental transient cerebral ischemia. J Neurosci Res. 2011;89: 1103-13.
16. Park OK, Yoo KY, Lee CH, Choi JH, Hwang IK, Park JH, et al. Arylalkylamine N-acetyltransferase (AANAT) is expressed in astrocytes and melatonin treatment maintains AANAT in the gerbil hippocampus induced by transient cerebral ischemia. J Neurol Sci. 2010;294:7-17.
17. Kim W, Kim DW, Yoo DY, Chung JY, Hwang IK, Won MH, et al. Neuroprotective effects of PEP-1-Cu,Zn-SOD against ischemic neuronal damage in the rabbit spinal cord. Neurochem Res. 2012;37:307-13.
18. Kimmich GA, Randles J, Brand JS. Assay of picomole amounts of ATP, ADP, and AMP using the luciferase enzyme system. Anal Biochem. 1975;69:187-206.
19. Katayama Y, Welsh FA. Effect of dichloroacetate on regional energy metabolites and pyruvate dehydrogenase activity during ischemia and reperfusion in gerbil brain. J Neurochem. 1989; 52:1817-22.
20. Lowry OH, Passonneau JV. A flexible system of enzymatic analysis. New York: Academic Press; 1972. p. 291.
21. Zou MH, Kirkpatrick SS, Davis BJ, Nelson JS, Wiles WG 4th, Schlattner U, et al. Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species. J Biol Chem. 2004;279: 43940-51.
22. Fryer LG, Hajduch E, Rencurel F, Salt IP, Hundal HS, Hardie DG, et al. Activation of glucose transport by AMP-activated protein kinase via stimulation of nitric oxide synthase. Diabetes. 2000;49:1978-85.
23. Choi SL, Kim SJ, Lee KT, Kim J, Mu J, Birnbaum MJ, et al. The regulation of AMP-activated protein kinase by H2O2. Biochem Biophys Res Commun. 2001;287:92-7.
24. McCullough LD, Zeng Z, Li H, Landree LE, McFadden J, Ronnett GV. Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke. J Biol Chem. 2005;280:20493-502.
25. Turnley AM, Stapleton D, Mann RJ, Witters LA, Kemp BE, Bartlett PF. Cellular distribution and developmental expression of AMP-activated protein kinase isoforms in mouse central nervous system. J Neurochem. 1999;72:1707-16.
26. Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HM. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 1986;17:1304-8.
27. Cole DJ, Drummond JC, Ghazal EA, Shapiro HM. A reversible component of cerebral injury as identified by the histochemical stain 2,3,5-triphenyltetrazolium chloride (TTC). Acta Neuropathol. 1990;80:152-5.
28. Hatfield RH, Mendelow AD, Perry RH, Alvarez LM, Modha P. Triphenyltetrazolium chloride (TTC) as a marker for ischaemic changes in rat brain following permanent middle cerebral artery occlusion. Neuropathol Appl Neurobiol. 1991; 17:61-7.
29. Kim EK, Miller I, Aja S, Landree LE, Pinn M, McFadden J, et al. C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase. J Biol Chem. 2004;279:19970-6.
30. Li J, Zeng Z, Viollet B, Ronnett GV, McCullough LD. Neuroprotective effects of adenosine monophosphate-activated protein kinase inhibition and gene deletion in stroke. Stroke. 2007;38:2992-9.
31. Li J, Benashski SE, Siegel C, Liu F, McCullough LD. Adenosine monophosphate activated protein kinase inhibition is protective in both sexes after experimental stroke. Neurosci Lett. 2010;482:62-5.
32. Li J, McCullough LD. Effects of AMP-activated protein kinase in cerebral ischemia. J Cereb Blood Flow Metab. 2010;30:480-92.
33. Culmsee C, Monnig J, Kemp BE, Mattson MP. AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation. J Mol Neurosci. 2001;17:45-58.
34. Katsuta K, Umemura K, Ueyama N, Matsuoka N. Pharmacological evidence for a correlation between hippocam-pal CA1 cell damage and hyperlocomotion following global cerebral ischemia in gerbils. Eur J Pharmacol. 2003;467:103-9.
35. Colbourne F, Corbett D. Delayed postischemic hypothermia: a six month survival study using behavioral and histological assessments of neuroprotection. J Neurosci. 1995;15:7250-60
36. Wang D, Corbett D. Cerebral ischemia, locomotor activity and spatial mapping. Brain Res. 1990;533:78-82.
37. Petito CK, Morgello S, Felix JC, Lesser ML. The two patterns of reactive astrogliosis in postischemic rat brain. J Cereb Blood Flow Metab. 1990;10:850-9.
38. Hwang IK, Yoo KY, Kim DW, Choi SY, Kang TC, Kim YS, et al. Ionized calcium-binding adapter molecule 1 immunoreactive cells change in the gerbil hippocampal CA1 region after ischemia/reperfusion. Neurochem Res. 2006;31:957-65.
39. Levy DE, Duffy TE. Cerebral energy metabolism during transient ischemia and recovery in the gerbil. J Neurochem. 1977;28:63-70.
40. Nowak TS Jr, Fried RL, Lust WD, Passonneau JV. Changes in brain energy metabolism and protein synthesis following transient bilateral ischemia in the gerbil. J Neurochem. 1985; 44:487-94.
41. Marmolino D, Manto M, Acquaviva F, Vergara P, Ravella A, Monticelli A, et al. PGC-1alpha down-regulation affects the antioxidant response in Friedreich's ataxia. PLoS One. 2010; 5:e10025.
42. Yu L, Yang SJ. AMP-activated protein kinase mediates activity-dependent regulation of peroxisome proliferator-activated receptor c coactivator-1a and nuclear respiratory factor 1 expression in rat visual cortical neurons. Neuroscience. 2010; 169:23-38.
43. Zhu L, Wang Q, Zhang L, Fang Z, Zhao F, Lv Z, et al. Hypoxia induces PGC-1a expression and mitochondrial biogenesis in the myocardium of TOF patients. Cell Res. 2010;20: 676-87